v3.24.1.1.u2
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balances at Dec. 31, 2022 $ 217,048 $ 58 $ 670,223 $ (618) $ (452,615)
Common Stock Balance, Shares at Dec. 31, 2022   57,499,541      
Exercise of common stock options 314   314    
Exercise of common stock options, Shares   53,060      
Issuance of common stock under Employee Stock Purchase Plan 1,097   1,097    
Issuance of common stock under Employee Stock Purchase Plan, Shares   239,060      
Vesting of restricted stock units, Shares   801,769      
Stock transaction associated with taxes withheld on restricted stock units (451)   (451)    
Stock transaction associated with taxes withheld on restricted stock units,Shares   (73,003)      
Stock-based compensation expense 6,021   6,021    
Issuance of common stock in connection with At-The-Market sale, net of issuance costs 10,923 $ 2 10,921    
Issuance of common stock in connection with At-The-Market sale, net of issuance costs, Shares   1,641,374      
Net unrealized gain (loss) on available-for-sale securities 511     511  
Net loss (50,050)       (50,050)
Balances at Mar. 31, 2023 185,413 $ 60 688,125 (107) (502,665)
Common Stock Balance, Shares at Mar. 31, 2023   60,161,801      
Balances at Dec. 31, 2023 149,649 $ 61 708,975 21 (559,408)
Common Stock Balance, Shares at Dec. 31, 2023   61,009,829      
Exercise of common stock options 117   117    
Exercise of common stock options, Shares   23,748      
Issuance of common stock under Employee Stock Purchase Plan 911   911    
Issuance of common stock under Employee Stock Purchase Plan, Shares   284,362      
Vesting of restricted stock units   $ 1 (1)    
Vesting of restricted stock units, Shares   1,215,729      
Stock transaction associated with taxes withheld on restricted stock units (374)   (374)    
Stock transaction associated with taxes withheld on restricted stock units,Shares   (77,122)      
Stock-based compensation expense 6,068   6,068    
Net unrealized gain (loss) on available-for-sale securities (134)     (134)  
Net loss (58,213)       (58,213)
Balances at Mar. 31, 2024 $ 98,024 $ 62 $ 715,696 $ (113) $ (617,621)
Common Stock Balance, Shares at Mar. 31, 2024   62,456,546